Advantages and challenges of ex vivo generation and expansion of human hematopoietic stem cells from pluripotent stem cells
Experimental Hematology · 2025-05 · 145 · 104752
DOI: 10.1016/j.exphem.2025.104752 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental Hematology, 2025-05. Verfasst von Min Ding und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Regenerative Medicine, and Department of Dermatology, Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang, Jiangsu,…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Cell Differentiation, Pluripotent Stem Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: Science and Technology Planning Project of Guangdong Province, National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Hematopoietic stem cell transplantation (HSCT) is an essential and increasing therapeutic approach for treating conditions such as leukemia, lymphoma, and other blood cancers. However, its widespread use faces significant challenges, including limited donor availability, pathogens, and the risk of immune rejection. The emergence of pluripotent stem cells (PSCs) offers a potential solution to these challenges. By enabling the generation of hematopoietic stem cells (HSCs) and blood cells in vitro, PSCs open pathways to address the limitations of traditional HSC sources. Self-induced or gene-edited PSCs from patients may provide an accessible and personalized option for clinical applications. In this review, we examine the current protocols for differentiating PSCs into HSCs and blood cells, highlighting their benefits and shortcomings. Despite advancements in this field, two primary challenges persist: low differentiation efficiency and difficulties in isolating and enriching functional HSCs. These problems make it difficult to obtain HSCs for long-term survival. Thus, we propose innovative strategies and potential improvements including induction scheme optimization, reprogramming, and cell fate tracking. Future research should prioritize the development of efficient and reliable differentiation protocols for PSCs to obtain more functional HSCs. Additionally, establishing effective methods for enriching functional HSCs and blood cells will be critical for optimizing their use in clinical applications. These efforts hold the promise of overcoming current limitations and advancing the therapeutic potential of PSC-derived blood cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Regenerative Medicine, and Department of Dermatology, Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang, Jiangsu, China; Haihe Laboratory of Cell Ecosystem, Institute of Hematology, C…
- Institute of Regenerative Medicine, and Department of Dermatology, Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang, Jiangsu, China.
Förderung
- Science and Technology Planning Project of Guangdong Province
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Ding, M., Lu, Y., Lei, Q. K., & Zheng, Y. W. (2025). Advantages and challenges of ex vivo generation and expansion of human hematopoietic stem cells from pluripotent stem cells. Experimental Hematology, 145, 104752. https://doi.org/10.1016/j.exphem.2025.104752
Vancouver
Ding M, Lu Y, Lei QK, Zheng YW. Advantages and challenges of ex vivo generation and expansion of human hematopoietic stem cells from pluripotent stem cells. Experimental Hematology. 2025;145:104752. doi:10.1016/j.exphem.2025.104752
BibTeX
@article{Ding2025,
author = {Ding, Min and Lu, Yu and Lei, Quan-Kai and Zheng, Yun-Wen},
title = {Advantages and challenges of ex vivo generation and expansion of human hematopoietic stem cells from pluripotent stem cells},
journal = {Experimental Hematology},
year = {2025},
volume = {145},
pages = {104752},
doi = {10.1016/j.exphem.2025.104752}
}
EUVIMED